{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:15:15Z","timestamp":1768868115148,"version":"3.49.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a rare autosomal dominant syndrome that is characterized by renal cell carcinoma, cutaneous leiomyomas, and uterine leiomyomas. Although HLRCC is usually identified in individuals with multiple cutaneous leiomyomas or a personal or family history of renal cell carcinoma, advances in histopathology have allowed detection of HLRCC in myomectomy and hysterectomy specimens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CASE:<\/jats:title>\n            <jats:p>A 36-year-old patient with a large leiomyoma was referred to gynecology for heavy menstrual bleeding. After no response to medical management, she proceeded with elective myomectomy. Fumarate hydratase (FH) immunohistochemical staining of the myomectomy specimen and subsequent molecular genetic analysis of the <jats:italic toggle=\"yes\">FH<\/jats:italic> gene confirmed a diagnosis of HLRCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>As more patients with HLRCC are identified with a primary presentation of leiomyomas, it is essential that gynecologists are familiar with this diagnosis. Health care professionals should inquire about skin lesions and family history of renal cell carcinoma in patients with symptomatic leiomyomas and refer patients with risk factors or pathology findings suggestive of HLRCC for genetic counseling.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/og9.0000000000000058","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:00:37Z","timestamp":1738274437000},"page":"e058","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Hereditary Leiomyomatosis and Renal Cell Cancer in a Patient With Isolated Uterine Leiomyomas"],"prefix":"10.1097","volume":"2","author":[{"given":"Shakiba","family":"Ardestani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"McGrattan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2]]},"reference":[{"key":"R1-20250130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archderm.141.2.199","article-title":"Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome","volume":"141","author":"Alam","year":"2005","journal-title":"Arch Dermatol"},{"key":"R2-20250130","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.euo.2019.11.002","article-title":"Hereditary leiomyomatosis and renal cell cancer: clinical, molecular, and screening features in a cohort of 185 affected individuals","volume":"3","author":"Forde","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"R3-20250130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"R4-20250130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.15586\/jkcvhl.v9i2.222","article-title":"Hereditary leiomyomatosis and renal cell cancer\u2013recognizing patterns may save lives","volume":"9","author":"Catarina","year":"2022","journal-title":"J Kidney Cancer VHL"},{"key":"R5-20250130","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-20250130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","article-title":"Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis","volume":"79","author":"Smit","year":"2011","journal-title":"Clin Genet"},{"key":"R7-20250130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13023-020-01653-9","article-title":"Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review","volume":"16","author":"Chayed","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R8-20250130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","article-title":"Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics","volume":"10","author":"Lehtonen","year":"2011","journal-title":"Fam Cancer"},{"key":"R9-20250130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R10-20250130","doi-asserted-by":"crossref","first-page":"E214","DOI":"10.5489\/cuaj.3798","article-title":"Structured assessment and followup for patients with hereditary kidney tumour syndromes","volume":"10","author":"Lattouf","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"R11-20250130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10689-019-00155-3","article-title":"Renal cell carcinoma in young FH mutation carriers: case series and review of the literature","volume":"19","author":"Hol","year":"2020","journal-title":"Fam Cancer"}],"container-title":["O&amp;G Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/og9.0000000000000058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:00:41Z","timestamp":1738274441000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/og9.0000000000000058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/og9.0000000000000058","relation":{},"ISSN":["2994-9726"],"issn-type":[{"value":"2994-9726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"2024-09-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}